The Importance of Proteasome Inhibitors in Myeloma and Their Evolution in the New Age of Myeloma Therapy with Dr. Jacob Laubach, MD, MPP, Dana Farber Cancer Institute

Myeloma Patient and Expert Roundtable Empowers Patients for Better Outcomes - Salt Lake City Round Table May 7th, 2016

What Drives Myeloma Relapse? Myeloma Stem Cells May be the Cause with Dr. William Matsui, MD, Johns Hopkins School of Medicine

Nanotechnology in Multiple Myeloma with Dr. Samuel Achilefu, Dr. Ravi Vij and Dr. Monica Shokeen, Washington University

The Road to Myeloma Recovery During and After Myeloma Treatment with Melanie House, DPT, NCS

Not Giving Up on Treatment Options for Relapsed/Refractory Myeloma Patients with Dr. David Siegel, MD, PhD, John Theurer Cancer Center

Preventing Myeloma Before it Gets Started with Dr. Irene Ghobrial, MD, Dana Farber Cancer Institue

Achieving Minimal Residual Disease with Myeloma Vaccines with Dr. David Avigan, MD Beth Israel Deaconess Medical Center

Combining Myeloma Vaccines and T Cell Therapies with Stem Cell Transplant with Dr. Muzaffar Qazilbash, MD, MD Anderson Cancer Center